Levodopa.
D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism; D010648:Phenylacetates / Q000134:cerebrospinal fluid; D011736:Pyridoxine / Q000494:pharmacology; D013997:Time Factors
D010648:Phenylacetates; D004295:Dihydroxyphenylalanine; D011736:Pyridoxine